about
Nurse self-evaluation of assessment of chemotherapy-induced peripheral neuropathy in patients with cancer.Chemotherapy-Induced Peripheral Neuropathy in Pediatric Cancer Patients.Profound and persistent painful paclitaxel peripheral neuropathy in a premenopausal patient.Retinoic acid reduces chemotherapy-induced neuropathy in an animal model and patients with lung cancer.Assessment of chemotherapy-induced peripheral neuropathy using the LDIFLARE technique: a novel technique to detect neural small fiber dysfunctionAssessing the impact of chemotherapy-induced peripheral neurotoxicity on the quality of life of cancer patients: the introduction of a new measure.Chemotherapy-induced peripheral neurotoxicity.Palliative chemotherapy followed by methylation inhibitor in high-risk acute myeloid leukemia: An in vitro and clinical study.A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101.Acupuncture combined with methylcobalamin for the treatment of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma.Nerve excitability assessment in chemotherapy-induced neurotoxicity.The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings.Chemotherapy-induced peripheral neuropathy in cancer patients: a four-arm randomized trial on the effectiveness of electroacupuncture.Acetyl-L-carnitine and prevention of chemotherapy-induced peripheral neuropathy: can anything work?Quantitative assessment of chemotherapy-induced peripheral neurotoxicity using a point-of-care nerve conduction deviceA prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen.Neuromuscular symptoms in cancer patients.Measuring vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.Evaluation of chemotherapy-induced peripheral neuropathy using current perception threshold and clinical evaluations.Chemotherapy-induced peripheral neuropathies: from clinical relevance to preclinical evidence.Chemotherapy-induced peripheral neurotoxicity (CIPN): what we need and what we know.Acupuncture for the management of chemotherapy-induced peripheral neuropathy.Ototoxicity (cochleotoxicity) classifications: A review.Goshajinkigan for reducing chemotherapy-induced peripheral neuropathy: protocol for a systematic review and meta-analysis.Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey.Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy.Investigation of a correlation between taxane-based chemotherapy and the ultrasonic time-of-flight of human fingernails.Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial.Case report of a patient with chemotherapy-induced peripheral neuropathy treated with manual therapy (massage).Electroclinical biomarkers of early peripheral neurotoxicity from oxaliplatin.Impact of oxaliplatin-induced neuropathy: a patient perspective.Burden of chemotherapy-induced neuropathy--a cross-sectional study.Multi-center assessment of the Total Neuropathy Score for chemotherapy-induced peripheral neurotoxicity.Pain in cancer survivors.
P2860
Q33885675-197C3C70-4CF6-4D44-835D-F4A132AACB25Q33889319-63E4AA04-8BA4-4B12-8DA1-FEF39D90BEDAQ34303792-96D3C5A4-5F0F-413D-9DAC-37A5881BE590Q35210260-A4FCBB55-06CB-43BC-A7CD-8D3E8D24BA7AQ35722135-7914FC4D-F71C-42F3-86AC-0628816BC0F1Q35815721-1BB7B17A-51B7-4714-A5D8-A6AF067C7744Q35925635-94B89D39-4D4D-4392-8926-061599DA3B89Q35948096-3A06FC08-9B0A-46C0-B199-24333E32E5A7Q36243420-90BE2183-F1E4-4643-9835-7B3B4CFD6D7BQ36244607-E8E8197E-7EA0-4A41-BD67-0F7829A42E21Q36304436-20BB845F-8B79-45F6-A715-80C7C4CAE19EQ36551631-0C970BF4-693A-427F-B6EB-B30394117F52Q37166705-424BD31B-2265-43C0-A266-AF56B3199F57Q37301431-7345B4AC-577D-472B-ABF5-DBC50540FA55Q37375212-3C329E0B-CE5F-4EF6-9501-9EB7335E371CQ37383249-2E5908E3-C732-4A85-A129-1A2DC552F0A1Q37610230-2B91607B-B105-4AAD-B0A5-8A0E18A9FF73Q37632970-6430B6E1-26C7-45D1-9D79-743816C1A133Q37672348-05472360-18E8-4714-AB3D-4B4405364406Q37826427-E416A4ED-7351-47FD-B272-79DDC15439AFQ38224422-4C999EBB-52B3-4FB2-B08D-8B77E1F98CD4Q38230413-D7296DE1-3146-4592-B173-CB9CF853D495Q38653146-FA4A8FAC-3317-4CBB-97E2-0730C82F699BQ39021089-F09C6225-D244-4F40-B23A-379835FCBAA2Q39356105-7BD6014D-D135-4C11-BEC8-B46BD26FB492Q43278321-7E88D8DB-E33C-4C23-829C-A32F2099D90CQ48323694-381B2843-805F-42D7-8EFD-0FA435E98055Q48443184-B631FFDA-C668-483A-AF2F-5D368963A528Q48628689-B3AF889F-B478-4583-88A0-3B788363FE5DQ49169362-4CD3D63C-85CD-4608-A30D-3C453065698DQ50956973-7A1FD9E0-E62B-446F-8685-B5CD460E6F2DQ51743346-3F0F1250-B4D6-4C8A-A6BE-C2C493283F57Q51939446-243FE0D3-94E9-4982-A570-6A9F769928D0Q54960570-3AA703F8-FDC0-40BC-AF52-FFE7B3840E37
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Grading of chemotherapy-induced peripheral neuropathy.
@ast
Grading of chemotherapy-induced peripheral neuropathy.
@en
type
label
Grading of chemotherapy-induced peripheral neuropathy.
@ast
Grading of chemotherapy-induced peripheral neuropathy.
@en
prefLabel
Grading of chemotherapy-induced peripheral neuropathy.
@ast
Grading of chemotherapy-induced peripheral neuropathy.
@en
P356
P1433
P1476
Grading of chemotherapy-induced peripheral neuropathy.
@en
P2093
J J Heimans
T J Postma
P304
P356
10.1023/A:1008345613594
P577
2000-05-01T00:00:00Z